Pharmacodynamics and stability of subcutaneously infused glucagon in a type 1 diabetic swine model in vivo

Diabetes Technology and Therapeutics

Volumn 9, Issue 2, 2007, Pages 135-144

  El Khatib, Firas H ^a   Jiang, John ^a   Gerrity, Ross G ^b   Damiano, Edward R ^a  

^a Boston University   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; GLUCOSE; INSULIN LISPRO;

AMBULATORY CARE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG STABILITY; DRUG STORAGE; GLUCOSE BLOOD LEVEL; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; ROOM TEMPERATURE; SWINE;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; GLUCAGON; HUMANS; HYPOGLYCEMIC AGENTS; INFUSIONS, PARENTERAL; INSULIN; INSULIN-SECRETING CELLS; MALE; SWINE;

EID: 34247527361     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2006.0006     Document Type: Article

References (12)

1. Plum A, Agerso H, Andersen L: Pharmacokinetics of the rapid-acting insulin analog, insulin aspart, in rats, dogs, and pigs, and pharmacodynamics of insulin aspart in pigs. Drug Metab Disp 2000;28:155-160.
2. Haymond MW, Schreiner B: Mini-dose glucagon rescue for hypoglycemia in children in type 1 diabetes. Diabetes Care 2001;24:643-645.
3. El-Khatib FH, Jiang J, Damiano ER: Adaptive closed-loop control provides blood-glucose regulation using dual subcutaneous insulin and glucagon infusion in diabetic swine. Diabetes Sci Tech 2007;1:181-192.
4. Gerrity RG, Natarajan R, Nadler JL, Kimsey T: Diabetes-induced accelerated atherosclerosis in swine. Diabetes 2001;50:1654-1665.
5. Jaremko J, Rorstad O: Advances toward the implantable artificial pancreas for treatment of diabetes. Diabetes Care 1998;21:444-450.
6. Albisser AM, Leibel BS, Ewart TG, Davidovac Z, Botz CK, Zingg W: An artificial endocrine pancreas. Diabetes 1974;23:389-396.
7. Clemens AH: Feedback control dynamics for glucose controlled insulin infusion systems. Med Prog Tech 1979;6:91-98.
8. Marliss EB, Murray FT, Stokes EF, Zinman B, Nakhooda AF, Denoga A, Leibel BS, Albisser AM: Normalization of glycemia in diabetes during meals with insulin and glucagon delivery by the artificial pancreas. Diabetes 1977;26:663-672.
9. Shichiri M, Kawamori R, Hakui N, Yamasaki Y, Abe H: Closed-loop glycemic control with a wearable artificial endocrine pancreas. Diabetes 1984;33:1200-1202.
10. Gerich GE, Langlois M, Noacco C, Karam J, Forsham PH: Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science 1973;182:171-173.
11. Carr JM, Sellke FW, Fey M, Doyle MJ, Krempin JA, Torre R, Liddicoat R: Implementing tight glucose control after coronary artery bypass surgery. Ann Thorac Surg 2005;80:902-909.
12. Van den Berghe GH, Wouters PJ, Weekers F: Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-1367.